These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related]
4. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Devarajan P; Mishra J; Supavekin S; Patterson LT; Steven Potter S Mol Genet Metab; 2003 Dec; 80(4):365-76. PubMed ID: 14654349 [TBL] [Abstract][Full Text] [Related]
12. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Burne-Taney MJ; Kofler J; Yokota N; Weisfeldt M; Traystman RJ; Rabb H Am J Physiol Renal Physiol; 2003 Jul; 285(1):F87-94. PubMed ID: 12657560 [TBL] [Abstract][Full Text] [Related]
15. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Lieberthal W; Nigam SK Am J Physiol Renal Physiol; 2000 Jan; 278(1):F1-F12. PubMed ID: 10644651 [TBL] [Abstract][Full Text] [Related]
16. Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia-reperfusion injury. Matsuyama M; Yoshimura R Expert Opin Biol Ther; 2004 Dec; 4(12):1931-7. PubMed ID: 15571455 [TBL] [Abstract][Full Text] [Related]
17. Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury. Xie J; Guo Q Am J Physiol Renal Physiol; 2007 Jan; 292(1):F107-15. PubMed ID: 16896190 [TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury. Ghielli M; Verstrepen WA; De Greef KE; Helbert MH; Ysebaert DK; Nouwen EJ; De Broe ME Kidney Int; 2000 Sep; 58(3):1121-34. PubMed ID: 10972676 [TBL] [Abstract][Full Text] [Related]